摘要
目的:探讨肝细胞肝癌(HCC)经肝动脉栓塞(TAE)治疗前后血清乏氧诱导因子-1α(HIF-1α)、血管内皮生成因子(VEGF)的表达及其与疗效的相关性。方法:2015年1月至2015年12月首诊HCC并行TAE36例,分别在TAE前1 d、TAE后3 d和1个月采集血清并行酶联免疫吸附试验(ELISA)测定血清HIF-1α和VEGF。根据TAE治疗后1个月复查疗效结果,将HCC患者分为完全缓解组与部分缓解+疾病稳定+进展组。结果:TAE前1 d血清HIF-1α和VEGF值分别为(136.56±69.36)和(287.83±125.74)ρg·ml^(-1),TAE后3 d分别为(325.15±36.21)和(395.17±98.36)ρg·ml^(-1),均显著高于TAE治疗前(P<0.05)。TAE后1个月,完全缓解组血清HIF-1α和VEGF值均低于部分缓解+疾病稳定+进展组(P<0.05)。血清HIF-1α、VEGF表达与疗效呈正相关(r=0.69,P<0.05)。结论:HCC患者TAE后短期内血清HIF-1α与VEGF均呈高表达,TAE后1个月血清HIF-1α及VEGF表达与疗效呈正相关。
Objective: To investigate the expression levels of hypoxia inducible factor-1 alpha( HIF-1α) and vascular endothelial growth factor( VEGF) before and after transcatheter arterial embolization( TAE) in hepatocellular carcinoma( HCC),and their correlations with therapeutic effects. Methods: Thirty-six consecutive patients fulfilling diagnostic criteria for HCC undergoing TAE from January 2015 to December 2015 were enrolled into this clinical study. The serum HIF-1α and VEGF levels of all patients were analyzed using enzyme-linked immunosorbent assay( ELISA) 1 day before-TAE,and 3 days,1 month after-TAE. All patients were divided into complete response( CR) and partial response( PR),stable disease( SD),progressive disease( PD) groups according to the therapeutic efficacy after one month. Results: The expression levels of serum HIF-1α and VEGF in HCC patients were( 136. 56 ± 69. 36) and( 287. 83 ± 125. 74) ρg·ml-(- 1)before TAE respectively. Three days after TAE,both serum HIF-1α( 325. 15 ± 36. 21) and VEGF levels( 395. 17 ± 98. 36) ρg·ml-(- 1)reached the peak values,and were higher than those before TAE( P〈0. 05). The levels of HIF-1αand VEGF in CR group after one month were significantly lower than those in PR + SD + PD group( P〈0. 05). The level of serum HIF-1α was positively correlated with serum VEGF level( r = 0. 69,P〈0. 05). Conclusion: The serum levels of HIF-1α and VEGF were in high expression in short time after TAE in HCC. The expression of HIF-1α and VEGF was positively correlated with clinical effects.
出处
《东南大学学报(医学版)》
CAS
北大核心
2016年第4期537-540,共4页
Journal of Southeast University(Medical Science Edition)
基金
南京市卫生科技发展一般项目(YKK14156)
江苏省肿瘤医院面上项目(ZM201504)
关键词
肝细胞肝癌
经肝动脉栓塞术
乏氧诱导因子-1Α
血管内皮生长因子
hepatocellular carcinoma
transcatheter arterial embolization
hypoxia inducible factor-1 alpha
vascular endothelial growth factor